Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma

Tissue Antigens

Volumn 70, Issue 1, 2007, Pages 12-17

  Wei, Y S ^a   Kuang, X H ^a   Zhu, Y H ^a   Liang, W B ^a   Yang, Z H ^a   Tai, S H ^a   Zhao, Y ^b   Zhang, L ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Interleukin 10; Nasopharyngeal carcinoma; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CARCINOMA; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HOMOZYGOTE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34250027045     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00806.x     Document Type: Article

References (46)

1. McDermott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 2001 : 26 : 82 92.
2. Chen DL, Huang TB. A case-control study of risk factors of nasopharyngeal carcinoma. Cancer Lett 1997 : 117 : 17 22.
3. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002 : 12 : 421 9.
4. Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V. Environmental risk factors for nasopharyngeal carcinoma: a case-control study in northeastern Thailand. Cancer Epidemiol Biomarkers Prev 1992 : 1 : 345 8.
5. Zheng X, Yan L, Nilsson B, Eklund G, Drettner B. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China. Acta Oncol 1994 : 33 : 867 72.
6. Cao Y, Miao XP, Huang MY et al. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 2006 : 6 : 167.
7. Hirankarn N, Kimkong I, Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue Antigens 2004 : 64 : 588 92.
8. Catarino RJ, Breda E, Coelho V et al. Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma. Head Neck 2006 : 28 : 603 8.
9. Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 2005 : 78 : 1043 51.
10. Uwatoko N, Tokunaga T, Hatanaka H et al. Expression of interleukin-10 is inversely correlated with distant metastasis of renal cell carcinoma. Int J Oncol 2002 : 20 : 729 33.
11. Neuner A, Schindel M, Wildenberg U, Muley T, Lahm H, Fischer JR. Prognostic significance of cytokine modulation in non-small cell lung cancer. Int J Cancer 2002 : 101 : 287 92.
12. Kozlowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst 2003 : 48 : 82 4.
13. De Vita F, Orditura M, Galizia G et al. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest 2000 : 117 : 365 73.
14. Budiani DR, Hutahaean S, Haryana SM, Soesatyo MH, Sosroseno W. Interleukin-10 levels in Epstein-Barr virus-associated nasopharyngeal carcinoma. J Microbiol Immunol Infect 2002 : 35 : 265 8.
15. Fujieda S, Lee K, Sunaga H et al. Staining of interleukin-10 predicts clinical outcome in patients with nasopharyngeal carcinoma. Cancer 1999 : 85 : 1439 45.
16. Kingo K, Ratsep R, Koks S, Karelson M, Silm H, Vasar E. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. J Dermatol Sci 2005 : 37 : 111 3.
17. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997 : 24 : 1 8.
18. Tseng LH, Lin MT, Shau WY et al. Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan. Tissue Antigens 2006 : 67 : 127 33.
19. Langsenlehner U, Krippl P, Renner W et al. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat 2005 : 90 : 113 5.
20. Havranek E, Howell WM, Fussell HM, Whelan JA, Whelan MA, Pandha HS. An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. J Urol 2005 : 173 : 709 12.
21. John SW, Weitzner G, Rozen R, Scriver CR. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991 : 19 : 408.
22. Roh JW, Kim MH, Seo SS et al. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett 2002 : 184 : 57 63.
23. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005 : 15 : 97 8.
24. Stephens M, Smith MJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001 : 68 : 978 89.
25. Lee JY, Kim HY, Kim KH et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 2005 : 225 : 207 14.
26. Ide A, Kawasaki E, Abiru N et al. Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol 2002 : 63 : 690 5.
27. Scassellati C, Zanardini R, Squitti R et al. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neurosci Lett 2004 : 35 : 119 22.
28. Alonso R, Suarez A, Castro P, Lacave AJ, Gutierrez C. Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease. Melanoma Res 2005 : 15 : 53 60.
29. Mangia A, Santoro R, Piattelli M et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 2004 : 25 : 103 9.
30. Biggs MW, Eiselein JE. Suppression of immune surveillance in melanoma. Med Hypotheses 2001 : 56 : 648 52.
31. Nemunaitis J, Fong T, Shabe P, Martineau D, Ando D. Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma. Cancer Invest 2001 : 19 : 239 47.
32. Gerlini G, Tun-Kyi A, Dudli C, Burg G, Pimpinelli N, Nestle FO. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol 2004 : 165 : 1853 63.
33. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics 1996 : 45 : 82 3.
34. Howell WM, Turner SJ, Bateman AC, Theaker JM. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immun 2001 : 2 : 25 31.
35. McCarron SL, Edwards S, Evans PR et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002 : 62 : 3369 72.
36. El-Omar EM, Rabkin CS, Gammon MD et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003 : 124 : 1193 201.
37. Stanczuk GA, Sibanda EN, Perrey C et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer 2001 : 94 : 792 4.
38. Zheng C, Huang D, Liu L et al. Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int J Cancer 2001 : 95 : 184 8.
39. Wu MS, Huang SP, Chang YT et al. Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 2002 : 185 : 106 9.
40. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003 : 104 : 617 23.
41. Shin HD, Park BL, Kim LH et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003 : 12 : 901 6.
42. Alamartine E, Berthoux P, Mariat C, Cambazard F, Berthoux F. Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol 2003 : 120 : 99 103.
43. Cunningham LM, Chapman C, Dunstan R, Bell MC, Joske DJ. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 2003 : 44 : 251 5.
44. Lech-Maranda E, Baseggio L, Bienvenu J et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 2004 : 103 : 3529 34.
45. Giordani L, Bruzzi P, Lasalandra C et al. Polymorphisms of Interleukin-10 and tumour necrosis factor-a gene promoter and breast cancer risk. Clin Chem 2004 : 49 : 1664 7.
46. Seifart C, Plagens A, Dempfle A et al. TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers 2005 : 21 : 157 65.